Pharmaceutical industry – Page 8
-
FeatureUsing genetics to personalise prescriptions
We’ve known for a long time that different people respond to certain drugs to very different extents, but now cheap DNA testing could make these disparities a thing of the past, as Ian Le Guillou reports
-
OpinionCatalogues of complexity
The tangled web of fine chemicals supply frequently throws up surprises
-
BusinessWhat is the future of Covid-19 pharmaceuticals?
Firms anticipate long-term markets for prevention and treatment
-
FeatureThe incredible antibodies of sharks, llamas and camels
Sharks and llamas share a strange quirk of their immune systems. Hayley Bennett finds out how their ‘nanobodies’ could help us tackle Covid and a host of other diseases
-
OpinionLetters: May 2022
Readers reminisce about a smelly interview question and curl up with their favourite arrow-based textbook
-
OpinionExit strategy
Overcoming a major setback showed Derek Lowe could make it through graduate school
-
WebinarSpeed up process development by making more from your offline and online data
Learn how the biotechnology R&D team at Clariant uses statistical modelling techniques to speed up the process development of their bio-ethanol product
-
BusinessUK takes subscription approach for new antibiotics
Decoupling payment from prescriptions helps preserve last-line antibiotics and encourage R&D
-
BusinessUkraine’s chemicals industry survives weeks of war
Russian invasion pushes firms to the limits as facilities are damaged and distribution networks break down
-
NewsUK’s non-profit vaccine manufacturing centre sold off before opening
Pharmaceutical firm Catalent buys government-backed facility near Oxford
-
FeatureA decade of CAR-T cell therapy
Nina Notman looks at the revolutionary treatment already taking on cancer, now aiming for wider use
-
BusinessWar in Ukraine prompts companies to quit Russia
Sectors supplying medicines and food try to reduce impact on civilians
-
OpinionA spanner in the works
Most drugs work by breaking or stopping something, rather than by making something faster or better
-
BusinessPatent office cements priority for Crispr gene editing in cells
Nobel laureates’ failed challenge means companies may need extra patent licenses
-
BusinessModerna sued over Covid-19 vaccine-related patents
Arbutus and Genevant say lipid nanoparticles that protect mRNA infringe six key patents
-
BusinessGSK accuses former employee of trade secret theft
Denise Brooks allegedly stole information about company’s manufacturing and quality systems
-
OpinionScents and sentimentality
Deprived of familiar lab odours, Derek Lowe indulges in some nasal nostalgia
-
BusinessTrials start of mRNA vaccine for HIV
First steps towards protection from the many and variable viral strains
-
NewsExplainer: How do the Covid vaccines measure up against each other and omicron?
Looking at how the evidence stacks up for vaccines against variants and how their performance holds up over time
-
OpinionThe shadow of drug resistance
Why do some medicines stop working, and can we avoid it for Covid-19 antivirals?